Revenue Breakdown
Composition ()
No data
Revenue Streams
Profitability & Margins
Evaluating the bottom line, AVITA Medical Inc maintains a gross margin of 81.90%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -55.03%, while the net margin is -65.97%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively RCEL converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, RCEL competes directly with industry leaders such as NNOX and NYXH. With a market capitalization of $147.34M, it holds a significant position in the sector. When comparing efficiency, RCEL's gross margin of 81.90% stands against NNOX's -83.61% and NYXH's 60.50%. Such benchmarking helps identify whether AVITA Medical Inc is trading at a premium or discount relative to its financial performance.
